Cargando…
Clinically Relevant Drug Interactions in the Cancer Setting
Along with the fast pace of oncology drug approvals is the heightened opportunity for drug-drug, drug-food, and drug-herbal interactions. Attendees at the JADPRO Live Virtual 2021 conference learned about the pharmacodynamic and pharmacokinetic mechanisms of drug interactions and how to integrate ap...
Autor principal: | DeRemer, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126326/ https://www.ncbi.nlm.nih.gov/pubmed/35663182 http://dx.doi.org/10.6004/jadpro.2022.13.3.10 |
Ejemplares similares
-
Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
por: DeRemer, David L, et al.
Publicado: (2011) -
Developing Clinically Relevant Dissolution Specifications for Oral Drug Products—Industrial and Regulatory Perspectives
por: McAllister, Mark, et al.
Publicado: (2019) -
Management of Warfarin Anticoagulated Patients Choosing Hyperbaric Oxygen Treatments
por: DeRemer, Christina E., et al.
Publicado: (2019) -
A reference set of clinically relevant adverse drug-drug interactions
por: Kontsioti, Elpida, et al.
Publicado: (2022) -
Impact of an ambulatory care pharmacist on provider relative value units in a rural clinic
por: DeRemer, Christina E., et al.
Publicado: (2021)